🇺🇸 FDA
Patent

US 11085057

Compositions and methods for modifying a target nucleic acid

granted A61KA61K31/7088

Quick answer

US patent 11085057 (Compositions and methods for modifying a target nucleic acid) held by The Regents of the University of California expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/7088